Bile Duct Cancer Awareness Month - QnA Session with an Expert |
 | Dr. Ravi Gaur AM, MBBS, MD, MS Chief Operating Officer (COO), Oncquest Labs Ltd., New Delhi, India |
Pancreatic Cancer - A Basic Understanding
(Focus: Malaysia)
As mentioned in our earlier post, November is also for raising awareness about Pancreatic Cancer. Here is the transcript of our interview with Dr Sujit Chakraborty, Clinical Oncologist from Hospital Lam Was Ee, Malaysia.
Dr. Sujit Chakraborty is a specialist in Cancer Treatment, mainly in Medical Oncology and Radiotherapy. He has 27 years of experience in treating and managing cancer patients, both surgically and via radiotherapy. He has been actively involved in various Cancer Awareness programmes.
Dr. Sujit Chakraborty is a specialist in Cancer Treatment, mainly in Medical Oncology and Radiotherapy. He has 27 years of experience in treating and managing cancer patients, both surgically and via radiotherapy. He has been actively involved in various Cancer Awareness programmes.
|
Dr Sujit Chakraborty MBBS, MD Clinical Oncologist, Hospital Lam Wah Ee, Malaysia |
Lung Cancer - A Basic Understanding
(Focus: India)
As November is marked for raising awareness about Lung Cancer and Pancreatic Cancer, this month we are bringing to our readers observations/views of two of our highly experienced panel members. Below is the transcript of our interview with Dr. Bivas Biswas, Medical Oncologist from the Tata Medical Center, Kolkata.
He has 10+ years of experience in treating cancer patients and is actively involved in teaching/training medical students. He also is Section Editor in Indian Journal of Medical & Pediatric Oncology and is involved in reviewing journals like - Indian Journal of Pediatrics, BMC cancer, and Journal of Urology .
He has 10+ years of experience in treating cancer patients and is actively involved in teaching/training medical students. He also is Section Editor in Indian Journal of Medical & Pediatric Oncology and is involved in reviewing journals like - Indian Journal of Pediatrics, BMC cancer, and Journal of Urology .
|
Dr. Bivas Biswas DM [Medical Oncology, AIIMS] , MD [AIIMS], MBBS Medical Oncologist, Tata Medical Center, Kolkata |
Breast Cancer - A Basic Understanding
(Focus: India)
Cancer awareness is a continuous exercise that requires a multi-dimensional approach and proactive involvement of every stakeholder. Oncofocus, being a management consulting and research firm, will be publishing every month a short interview with leading Oncologists across the APAC region on a particular Cancer type. The main objective of these interviews is to learn the "What, Why, How" of the present state of cancer management directly from the treaters.
October being the Breast Cancer Awareness Month, we have dedicated two posts in our Cancer Interview series towards breast cancer awareness. In the fourth post of our Oncology interview series, our analyst Shimi Manayath Panakkal connected with Dr. Aparna S, Consultant Medical Oncologist.
October being the Breast Cancer Awareness Month, we have dedicated two posts in our Cancer Interview series towards breast cancer awareness. In the fourth post of our Oncology interview series, our analyst Shimi Manayath Panakkal connected with Dr. Aparna S, Consultant Medical Oncologist.
 | Dr Aparna S MD, DM (Medical Oncology), MRCP(UK) Consultant Medical Oncologist, Sahyadri Narayana Multi-specialty Hospital, Shimoga, Karnataka, India |
Breast Cancer - A Basic Understanding
(Focus: Australia)
Cancer awareness is a continuous exercise that requires a multi-dimensional approach and proactive involvement of every stakeholder. Oncofocus, being a management consulting and research firm, will be publishing every month a short interview with leading Oncologists across the APAC region on a particular Cancer type. The main objective of these interviews is to learn the "What, Why, How" of the present state of cancer management directly from the treaters.
October being the Breast Cancer Awareness Month, we have dedicated our next two posts in our Cancer Interview series on Breast Cancer Awareness. Our analyst Ms. Shilna Kunnath connected with Dr. Bhaumik Shah, Consultant Medical Oncologist from Aurora Specialists Care, Melbourne, Australia and discussed about the basics of breast cancer from the perspective of Australia.
October being the Breast Cancer Awareness Month, we have dedicated our next two posts in our Cancer Interview series on Breast Cancer Awareness. Our analyst Ms. Shilna Kunnath connected with Dr. Bhaumik Shah, Consultant Medical Oncologist from Aurora Specialists Care, Melbourne, Australia and discussed about the basics of breast cancer from the perspective of Australia.
In Australia, there is a nationalized screening of breast cancer... everybody above the age of 50 gets a free mammogram...there is a 95% cure rate in breast cancer, as it is detected in early stages
Lymphoma – A Basic Understanding
(Focus: India)
Cancer awareness is a continuous exercise that requires a multi-dimensional approach and proactive involvement of every stakeholder. Oncofocus, being a management consulting and research firm, will be publishing every month a short interview with leading Oncologists across the APAC region on a particular Cancer type. The main objective of these interviews is to learn the "What, Why, How" of the present state of cancer management directly from the treaters.
September being the Lymphoma Awareness Month, we decided to focus on lymphoma, in the second post of our cancer interview series. Our analyst Ms. Shilna Kunnath connected with Dr. Anil Kumar MR, consultant radiation oncologist and CEO of Bangalore Cancer Centre and discussed about lymphoma in general.
September being the Lymphoma Awareness Month, we decided to focus on lymphoma, in the second post of our cancer interview series. Our analyst Ms. Shilna Kunnath connected with Dr. Anil Kumar MR, consultant radiation oncologist and CEO of Bangalore Cancer Centre and discussed about lymphoma in general.
The advent of rituximab itself changed the prognosis of Non-Hodgkin’s lymphoma. Being a very specific, chimeric monoclonal antibody, it targets only the cells expressing CD20 marker.